Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Market Research Reveals Path To $1.86 Billion By 2030

The market for benign prostatic hyperplasia (BPH) treatment devices and equipment is set to experience notable expansion in the coming years. As advancements in medical technology continue and patient preferences evolve, this sector is positioned for significant growth and innovation. Below, we explore the market size, key players, emerging trends, and segmentation to provide a comprehensive view of this dynamic industry.

Expected Market Growth and Future Outlook for BPH Treatment Devices and Equipment
The benign prostatic hyperplasia treatment devices and equipment market is projected to reach a valuation of $1.86 billion by 2030, growing at a compound annual growth rate (CAGR) of 6.9%. This growth is driven by factors such as an aging male population, increasing preference for minimally invasive treatment options, the rise of outpatient urology clinics, wider adoption of laser and implant-based therapies, and a growing emphasis on reducing hospital stays. Key trends influencing the market include greater use of minimally invasive devices, increased application of laser-based prostate treatments, expanding demand for implantable devices, growth in office-based procedures, and heightened focus on patient comfort and faster recovery.

Download a free sample of the benign prostatic hyperplasia (bph) treatment devices and equipment market report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=2431&type=smp&utm_source=OpenPR&utm_medium=Paid&utm_campaign=Jul_PR

Key Drivers Fueling Growth in the BPH Treatment Devices and Equipment Market
One of the primary factors propelling the market forward is the increasing aging male demographic worldwide, which leads to a higher prevalence of BPH, thus boosting demand for effective treatment devices. Alongside this, there is a growing preference among patients and healthcare providers for minimally invasive therapies that offer quicker recovery and fewer complications compared to traditional surgical methods.

Expanding outpatient urology clinics and advancements in technology also play a crucial role. The rise in laser and implant-based treatments allows for procedures that can be performed in less intensive settings, reducing the need for lengthy hospital stays. This shift enhances patient convenience and optimizes healthcare resources, further supporting market expansion.

View the full benign prostatic hyperplasia (bph) treatment devices and equipment market report:
https://www.thebusinessresearchcompany.com/report/benign-prostatic-hyperplasia-bph-treatment-devices-and-equipment-global-market-report?utm_source=OpenPR&utm_medium=Paid&utm_campaign=Jul_PR

Prominent Companies Leading the BPH Treatment Devices and Equipment Market
The industry is shaped by a range of influential companies, including Karl Storz, Lumenis Ltd., Olympus Corporation, Urologix LLC, Boston Scientific Inc., NeoTract Inc., OmniGuide Inc., ProArc Medical Ltd., Urotech Devices, Prostalund Operations AB, NxThera Inc., Richard Wolf GmbH, Coloplast A/S, Biolitec AG, BVM Medical, Convergent Laser Technologies, Cook Medical, GreenLight Technologies, PROCEPT BioRobotics, and Quanta System.

Significant Market Activity: Acquisition Strengthens Product Portfolio
In October 2023, Laborie Medical Technologies Corp., based in the United States, acquired Urotronic Inc. for an undisclosed sum. This strategic move enhances Laborie's therapeutic urology offerings by incorporating Urotronic's Optilume drug-coated balloon technology, which supports minimally invasive treatment of urethral strictures and BPH. The acquisition expands Laborie's global reach and improves patient access to advanced, evidence-based urological therapies, broadening its portfolio of innovative interventional solutions. Urotronic is recognized for its production of BPH treatment devices and equipment.

Innovations and Trends Reshaping the BPH Treatment Devices and Equipment Industry
Leading companies in this market are focusing on developing innovative, minimally invasive solutions that improve treatment accessibility and reduce dependence on long-term medications or invasive tissue removal procedures. A key area of innovation is temporarily implantable devices designed to reshape the prostatic urethra and alleviate lower urinary tract symptoms (LUTS) caused by an enlarged prostate.

Expanding availability of such technologies is evident; for example, in February 2025, Olympus, a Japanese medical technology firm, announced wider distribution of its iTind device in major Asia-Pacific markets including Thailand, Australia, Hong Kong, Singapore, India, with plans to launch in Korea. The iTind is a temporarily implantable nitinol device that reshapes the prostatic urethra to improve urinary flow and quality of life. This minimally invasive procedure can be done in a clinic setting under local anesthesia and is supported by comprehensive physician training programs, facilitating clinical adoption. Recent guideline updates and reimbursement policies are further accelerating the uptake of this treatment.

Market Segmentation Breakdown for BPH Treatment Devices and Equipment
The BPH treatment devices and equipment market is segmented into several categories:

By Product Type:
- Resectoscopes
- Radiofrequency Ablation Devices
- Urology Lasers
- Prostatic Stents
- Implants

By Procedure Type:
- Transurethral Needle Ablation (TUNA)
- Transurethral Resection of Prostate (TURP)
- Transurethral Incision of Prostate (TUIP)
- Transurethral Microwave Thermotherapy (TUMT)
- Laser Surgery
- Other Procedure Types

By End-User:
- Hospitals
- Ambulatory Surgical Centres (ASC)
- Clinics
- Specialty Urology Centers

Further sub-segmentation includes:
By Resectoscopes: Bipolar Resectoscopes, Monopolar Resectoscopes, High-Performance Resectoscopes
By Radiofrequency Ablation Devices: Single-Needle and Multi-Needle variants
By Urology Lasers: Holmium Lasers, Diode Lasers, Green Light Lasers
By Prostatic Stents: Temporary and Permanent Prostatic Stents
By Implants: Prostatic Urethral Lift (PUL) Implants, Balloon-Expandable Stents, and Permanent Implants for BPH Treatment

This detailed segmentation provides insight into the diverse range of products, procedures, and care settings shaping the BPH treatment devices and equipment market.

Our 2026 market reports now include enhanced strategic insights through:

• Market attractiveness scoring and analysis
• Total addressable market (TAM) analysis
• Company scoring matrix graphics and tables
• Excel-based forecasting dashboards
• Market hotspots infographics
• Key technologies and future trend analysis
• Updated graphics and tables

Reach out to us:
The Business Research Company: https://www.thebusinessresearchcompany.com/,
Americas +1 310-496-7795,
Europe +44 7882 955267,
Asia & Others +44 7882 955267 & +91 8897263534,
Email us at info@tbrc.info.

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Learn More About The Business Research Company
With over 17500+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.